Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance

Heart

Volumn 96, Issue 17, 2010, Pages 1407-1408

  Hill, R A ^a   Chung, H ^a   George, E ^a   Longson, C ^a   Stevens, A ^b  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EFIENT; PRASUGREL; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; PIPERAZINE DERIVATIVE; THIOPHENE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANTICOAGULATION; ATHEROSCLEROSIS; BLEEDING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG SCREENING; HEALTH CARE COST; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SHORT SURVEY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; PROCEDURES; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; THIOPHENES;

EID: 77956128799     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.202853     Document Type: Short Survey

References (5)

1. National Institute for Health and Clinical Excellence. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. NICE technology appraisal guidance 182. London: National Institute for Health and Clinical Excellence, 2009. http://www.guidance.nice.org.uk/TA182.
2. National Institute for Health and Clinical Excellence. Guide to the single technology appraisal (STA) process. London: National Institute for Health and Clinical Excellence, 2006.
3. Greenhalgh J, Bagust A, Boland A, et al. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: a single technology appraisal. The University of Liverpool: Liverpool Reviews and Implementation Group, 2009. http://www.nice.org.uk/nicemedia/live/12028/44534/ 44534.pdf (accessed 1 Apr 2010).
4. National Institute for Health and Clinical Excellence. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. Final Appraisal Determination. London: National Institute for Health and Clinical Excellence, 2009. http://www.nice.org.uk/nicemedia/live/12028/45321/ 45321.pdf (accessed 1 Apr 2010).
5. Wiviott SD, Braunwald E, McCabe CH, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.